Double-Blind, Comparative Study of Rufloxacin Once Daily Versus Amoxicillin Three Times a Day in Treatment of Outpatients With Exacerbations of Chronic Bronchitis.
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.37.11.2298
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 1993
Authors
Publisher
American Society for Microbiology